4.6 Article

Dendritic cells require the NF-κB2 pathway for cross-presentation of soluble antigens

期刊

JOURNAL OF IMMUNOLOGY
卷 181, 期 1, 页码 354-363

出版社

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.181.1.354

关键词

-

资金

  1. NCI NIH HHS [CA09143] Funding Source: Medline
  2. NIAID NIH HHS [R37 AI026296] Funding Source: Medline

向作者/读者索取更多资源

NF-kappa B-inducing kinase (NIK) is responsible for activation of the non-canonical p100 processing pathway of NF-kappa B activation. This kinase has been shown to be critical for activation of this pathway after signaling through several TNF family members including CD40. The functional importance of this pathway in CD40 and TLR-induced dendritic cell (DC) differentiation was studied in vivo in the alymphoplasia (Aly) mouse. The Aly mouse expresses a mutant NIK molecule that prohibits the induction of the non-canonical pathway. We show that while MHC class II presentation and in vivo migration of Aly DCs is intact, these cells are unable to cross-prime CD8(+) T cells to exogenous Ag. Gene expression array analysis of DCs matured in vivo indicates multiple defects in Ag processing pathways after maturation and provide a global view of the genes that are regulated by the NF-kappa B2 pathway in DCs. These experiments indicate a possible role for NIK in mediating cross-priming of soluble Ag. In addition, our findings explain the profound immune unresponsiveness of the Aly mouse.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Letter Immunology

Response to Are NKT cells a useful predictor of COVID-19 severity?

Stefanie Kreutmair, Burkhard Becher

IMMUNITY (2022)

Correction Immunology

Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia (vol 54, pg 1578, 2021)

Stefanie Kreutmair, Susanne Unger, Nicolas Gonzalo Nunez, Florian Ingelfinger, Chiara Alberti, Donatella De Feo, Sinduya Krishnarajah, Manuel Kauffmann, Ekaterina Friebel, Sepideh Babaei, Benjamin Gaborit, Mirjam Lutz, Nicole Puertas Jurado, Nisar P. Malek, Siri Goepel, Peter Rosenberger, Helene A. Haberle, Sally Al-Hajj, Ikram Ayoub, Jakob Nilsson, Manfred Claassen, Roland Liblau, Guillaume Martin-Blondel, Michael Bitzer, Antoine Roquilly, Burkhard Becher

IMMUNITY (2022)

Article Allergy

Azathioprine therapy induces selective NK cell depletion and IFN-g deficiency predisposing to herpesvirus reactivation

Florian Ingelfinger, Colin Sparano, David Bamert, David Reyes-Leiva, Aakriti Sethi, Lukas Rindlisbacher, Pascale Zwicky, Stefanie Kreutmair, Corinne C. Widmer, Sarah Mundt, Elena Cortes-Vicente, Sonia Tugues, Burkhard Becher, Bettina Schreiner

Summary: This study comprehensively investigates the risks and immune dysfunction associated with azathioprine therapy. Using single-cell mass and spectral flow cytometry, the specific effects of azathioprine on the systemic immune signature were analyzed. Clinical features associated with therapy were analyzed in two independent cohorts of myasthenia gravis patients. The study highlights the risk of adverse events during azathioprine therapy and suggests that monitoring natural killer cells could be valuable in clinical practice.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2023)

Meeting Abstract Hematology

CAR T Cells and Their Immune Environment Synergize to Shape Distinct Immune Profiles in Response Versus Toxicity in B Cell Lymphoma Patients

Stefanie Kreutmair, Maximilian M. Schaefer, Sebastian Stolz, Carla Merten, Can Ulutekin, Florian Ingelfinger, Susanne Unger, Chiara Alberti, Tobias Wertheimer, Aakriti Sethi, Thorsten Zenz, Markus G. Manz, Antonia Maria Susanne Mueller, Corinne C. Widmer, Burkhard Becher

Article Neurosciences

IGF1R expression by adult oligodendrocytes is not required in the steady-state but supports neuroinflammation

Giuseppe Locatelli, Filipa Marques-Ferreira, Antonis Katsoulas, Vasileia Kalaitzaki, Martin Krueger, Barbara Ingold-Heppner, Sabrina Walthert, Roman Sankowski, Olivia Prazeres da Costa, Amalia Dolga, Magdalena Huber, Maike Gold, Carsten Culmsee, Ari Waisman, Ingo Bechmann, Vladislava Milchevskaya, Marco Prinz, Achim Tresch, Burkhard Becher, Thorsten Buch

Summary: Research suggests that insulin-like growth factor 1 (IGF-1) signaling is not necessary for the function and survival of mature oligodendrocytes (ODCs) in the central nervous system (CNS). Lack of IGF-1 receptor in ODCs does not affect ODC survival and myelin status in toxin-induced and autoimmune demyelination models. Surprisingly, the absence of IGF-1 receptor in ODCs protects against clinical neuroinflammation in the autoimmune demyelination model.
Article Multidisciplinary Sciences

Active eosinophils regulate host defence and immune responses in colitis

Alessandra Gurtner, Costanza Borrelli, Ignacio Gonzalez-Perez, Karsten Bach, Ilhan E. Acar, Nicolas G. Nunez, Daniel Crepaz, Kristina Handler, Vivian P. Vu, Atefeh Lafzi, Kristin Stirm, Deeksha Raju, Julia Gschwend, Konrad Basler, Christoph Schneider, Emma Slack, Tomas Valenta, Burkhard Becher, Philippe Krebs, Andreas E. Moor, Isabelle C. Arnold

Summary: In the past decade, single-cell transcriptomics has provided insights into the biology of eosinophils, a difficult-to-sequence cell type, and their roles in intestinal homeostasis, immune regulation, and host defense. The study reveals the heterogeneity of eosinophils and the gene programs that underpin their pleiotropic functions. It also explains the mechanism by which interleukin-33 (IL-33) and interferon-gamma (IFN gamma) induce the accumulation of active eosinophils in the inflamed colon and their association with CD4(+) T cells.

NATURE (2023)

Article Dermatology

S100A9 Drives the Chronification of Psoriasiform Inflammation by Inducing IL-23/ Type 3 Immunity

Bruno Marcel Silva de Melo, Flavio Protasio Veras, Pascale Zwicky, Diogenes Lima, Florian Ingelfinger, Timna Varela Martins, Douglas da Silva Prado, Stefanie Scharli, Gabriel Publio, Carlos Hiroji Hiroki, Paulo Henrique Melo, Andre Saraiva, Thaina Norbiato, Leonardo Lima, Bernhard Ryffel, Thomas Vogl, Johannes Roth, Ari Waisman, Helder I. Nakaya, Cacilda da Silva Souza, Fernando Q. Cunha, Thiago M. Cunha, Burkhard Becher, Jose C. Alves-Filho

Summary: Psoriasis is a chronic inflammatory skin disorder driven by the IL-23/type 3 immune response. This study identified S100A9 as a highly up-regulated gene in psoriatic skin, which is produced by keratinocytes and induces IL-23 production by dendritic cells, driving the IL-23/type 3 immunity in psoriasiform inflammation.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2023)

Article Oncology

Blocking the CD47-SIRPα interaction reverses the disease phenotype in a polycythemia vera mouse model

Veronika Lysenko, Patrick M. Schurch, Selma Tuzlak, Nicole Wildner-Verhey van Wijk, Larisa V. Kovtonyuk, Burkhard Becher, Markus G. Manz, Stefanie Kreutmair, Alexandre P. A. Theocharides

Summary: Polycythemia vera (PV) is a hematopoietic stem cell neoplasm driven by JAK2 mutations that result in uncontrolled red blood cell (RBC) production. Blocking the CD47-SIRP alpha interaction can correct the polycythemia phenotype in a PV mouse model.

LEUKEMIA (2023)

Editorial Material Immunology

High-dimensional analysis of 16 SARS-CoV-2 vaccine combinations reveals lymphocyte signatures correlating with immunogenicity

Nicolas Gonzalo Nunez, Jonas Schmid, Laura Power, Chiara Alberti, Sinduya Krishnarajah, Stefanie Kreutmair, Susanne Unger, Sebastian Blanco, Brenda Konigheim, Constanza Marin, Luisina Onofrio, Jenny Christine Kienzler, Sara Costa-Pereira, Florian Ingelfinger, Fabio Cerban, Laura Chiapello, Carolina Montes, Cristina Motran, Jeremias Dutto, Laura Almada, Lucia Boffelli, Lorena Spinsanti, Adrian Diaz, Maria Elisa Rivarola, Javier Aguilar E. Bioq, Mauricio M. Beranek, Marina Pasinovich, Juan Castelli, Carla Vizzotti, Maximilian Schaefer, Juan Villar-Vesga, Sarah Mundt, Carla Helena Merten, Aakriti Sethi, Tobias Wertheimer, Mirjam Lutz, Danusia Vanoaica, Claudia Sotomayor, Adriana Gruppi, Christian Muenz, Diego Cardozo, Gabriela Barbas, Laura Lopez, Paula Carreno, Gonzalo Castro, Elias Raboy, Sandra Gallego, Gabriel V. Moron, Laura A. Cervi, Eva Acosta Rodriguez, Belkys Maletto, Mariana Maccioni, Burkhard Becher

Summary: A study analyzed the immune response of different COVID-19 vaccines (adenoviral, mRNA, and inactivated virus) in 16 combinations. Heterologous combinations of adenoviral and inactivated-virus vaccines were more immunogenic than homologous regimens. The mRNA vaccine as the second dose generated the strongest antibody response and highest frequency of spike-binding memory B cells regardless of the priming vaccine. Priming with inactivated-virus vaccine boosted the SARS-CoV-2-specific T cell response. Different vaccine combinations elicited distinct immune signatures, highlighting the importance of vaccine type and order of administration.

NATURE IMMUNOLOGY (2023)

Article Immunology

Age-induced alterations of granulopoiesis generate atypical neutrophils that aggravate stroke pathology

Giorgia Serena Gullotta, Donatella De Feo, Ekaterina Friebel, Aurora Semerano, Giulia Maria Scotti, Andrea Bergamaschi, Erica Butti, Elena Brambilla, Angela Genchi, Alessia Capotondo, Mattia Gallizioli, Simona Coviello, Marco Piccoli, Tiziana Vigo, Patrizia Della Valle, Paola Ronchi, Giancarlo Comi, Armando D'Angelo, Norma Maugeri, Luisa Roveri, Antonio Uccelli, Burkhard Becher, Gianvito Martino, Marco Bacigaluppi

Summary: Aging is associated with increased risk and worse outcome of ischemic stroke. Age-related changes in the immune system, particularly in neutrophil function, play a key role in this process. Aged mice and elderly patients with stroke exhibit enhanced granulopoiesis and accumulation of atypical mature and immature neutrophil subsets, which contribute to worse reperfusion and neurological outcome. Rejuvenation of hematopoietic stem cells can reverse aging-associated neutropoiesis and improve stroke outcome.

NATURE IMMUNOLOGY (2023)

Article Cell Biology

CD4+T cells produce GM-CSF and drive immune- mediated glomerular disease by licensing monocyte- derived cells to produce MMP12

Hans-Joachim Paust, Ning Song, Donatella De Feo, Nariaki Asada, Selma Tuzlak, Yu Zhao, Jan-Hendrik Riedel, Malte Hellmig, Amirrtavarshni Sivayoganathan, Anett Peters, Anna Kaffke, Alina Borchers, Ulrich O. Wenzel, Oliver M. Steinmetz, Gisa Tiegs, Elisabeth Meister, Matthias Mack, Christian Kurts, Sibylle von Vietinghoff, Maja T. Lindenmeyer, Elion Hoxha, Rolf A. K. Stahl, Tobias B. Huber, Stefan Bonn, Catherine Meyer-Schwesinger, Thorsten Wiech, Jan-Eric Turner, Burkhard Becher, Christian F. Krebs, Ulf Panzer

Summary: Glomerulonephritis is an immune-mediated disease that causes kidney inflammation and is a major cause of end-stage renal disease. T cells play a significant role in the development of glomerulonephritis, but the specific mechanisms are not well understood. This study identifies GM-CSF-producing T cells as key players in the pathogenesis of glomerulonephritis and shows that targeting GM-CSF or MMP12 can reduce disease severity in mouse models. These findings provide a potential therapeutic target for glomerulonephritis.

SCIENCE TRANSLATIONAL MEDICINE (2023)

Article Clinical Neurology

Antibodies Produced by CLL Phenotype B Cells in Patients With Myasthenia Gravis Are Not Directed Against Neuromuscular Endplates

Florian Ingelfinger, Michael Kramer, Mirjam Lutz, Corinne C. Widmer, Luca Piccoli, Stefanie Kreutmair, Tobias Wertheimer, Mark Woodhall, Patrick Waters, Federica Sallusto, Antonio Lanzavecchia, Sarah Mundt, Burkhard Becher, Bettina Schreiner

Summary: This study suggests that myasthenia gravis (MG) may be associated with hematologic malignancies such as chronic lymphocytic leukemia (CLL). It is unclear whether the leukemic B cells are directly responsible for the autoimmune response in patients with MG and CLL. However, treatment with the anti-CD20 therapy obinutuzumab has shown potential in effectively treating AChR(+) MG.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2023)

Article Medicine, Research & Experimental

Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors

Nicolas Gonzalo Nunez, Fiamma Berner, Ekaterina Friebel, Susanne Unger, Nina Wyss, Julia Martinez Gomez, Mette-Triin Purde, Rebekka Niederer, Maximilian Porsch, Christa Lichtensteiger, Rafaela Kramer, Michael Erdmann, Christina Schmitt, Lucie Heinzerling, Marie-Therese Abdou, Julia Karbach, Dirk Schadendorf, Lisa Zimmer, Selma Ugurel, Niklas Kluemper, Michael Hoelzel, Laura Power, Stefanie Kreutmair, Mariaelena Capone, Gabriele Madonna, Lacin Cevhertas, Anja Heider, Teresa Amaral, Omar Hasan Ali, David Bomze, Florentia Dimitriou, Stefan Diem, Paolo Antonio Ascierto, Reinhard Dummer, Elke Jaeger, Christoph Driessen, Mitchell Paul Levesque, Willem van de Veen, Markus Joerger, Martin Frueh, Burkhard Becher, Lukas Flatz

Summary: In this study, a multi-omics approach was used to characterize the systemic immune compartment of melanoma or non-small cell lung cancer patients before and during immune checkpoint inhibitor (ICI) treatment. Potential predictive biomarkers for ICI-induced immune-related adverse events (irAEs) were identified, including early increase in CXCL9/CXCL10/CXCL11 and interferon-g (IFN-g) 1 to 2 weeks after treatment initiation, as well as early expansion of Ki-67+ regulatory T cells (Tregs) and Ki-67+ CD8+ T cells.
Correction Medicine, Research & Experimental

NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22 (vol 126, 1783, 2016)

Marianne R. Spalinger, Stephanie Kasper, Claudia Gottier, Silvia Lang, Kirstin Atrott, Stephan R. Vavricka, Sylvie Scharl, Petrus M. Gutte, Markus G. Gruetter, Hans-Dietmar Beer, Emmanuel Contassot, Andrew C. Chan, Xuezhi Dai, David J. Rawlings, Florian Mair, Burkhard Becher, Werner Falk, Michael Fried, Gerhard Rogler, Michael Scharl

JOURNAL OF CLINICAL INVESTIGATION (2023)

Review Immunology

Immunity in malignant brain tumors: Tumor entities, role of immunotherapy, and specific contribution of myeloid cells to the brain tumor microenvironment

Jenny C. Kienzler, Burkhard Becher

Summary: Malignant brain tumors have a lack of effective treatment, but immunotherapy has become a focus in brain tumor research. Myeloid cells are found to dominate the tumor microenvironment and their interaction with tumor cells is complex.

EUROPEAN JOURNAL OF IMMUNOLOGY (2023)

暂无数据